News Headlines

  1. Terumo Blood And Cell Technologies Partners With South Korea's KBIOHealth To Help Develop Nation's Cell And Gene Therapy Workforce 3/18/2025

    Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, signed a memorandum of understanding (MOU) with Osong Medical Innovation Foundation (KBIOHealth) toward joint development of workforce training for cell and gene therapy (CGT) manufacturing.

  2. Leading Academic And Manufacturing Organizations Join Ori Biotech's Preferred Partner Network To Accelerate The Commercialization Of Cell And Gene Therapies 3/18/2025

    Oribiotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announced the launch of its Preferred Partner Network (PPN), bringing together top academic medical centers (AMCs) and contract development and manufacturing organizations (CDMOs) to deliver best-in-class solutions to accelerate development and commercialization of cell and gene therapies.

  3. Delpharm To Modernize Its Facilities And Ensure Continued Production Of Sterile Injectable Medicines In Boucherville 3/18/2025

    Delpharm, a world leader in pharmaceutical outsourcing, announced that it has reached an agreement with the Government of Canada to modernize its injectable manufacturing facility in Boucherville.

  4. Curia Announces Expansions To Global Network Of Sterile Fill-Finish Sites 3/17/2025
  5. Humanetics Selects Lifecore Biomedical To Deliver CDMO Services Supporting Development Of BIO 300 For The Prevention Of Acute Radiation Syndrome 3/17/2025

    Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and Humanetics Corporation (“Humanetics”), an advanced clinical-stage pharmaceutical company, today announced that Humanetics has selected Lifecore to provide a range of CDMO services to support the continued development of BIO 300 for the prevention of acute radiation syndrome.

  6. ChromaTan And Landmark Bio Awarded National Institute For Innovation In Manufacturing Biopharmaceuticals (NIIMBL) Grant To Advance Intensified Recombinant Adeno-Associated Virus (AAV) Production Process 3/17/2025

    ChromaTan Inc., and Landmark Bio PBLLC, today announced they have been awarded a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to support the development of an intensified recombinant adeno-associated virus (AAV) production process as part of NIIMBL's Viral Vector Manufacturing and Analytics Program.

  7. AstraZeneca Enters License Agreement With Alteogen For Subcutaneous Formulations Of Multiple Oncology Assets 3/17/2025

    AstraZeneca and Alteogen Inc. have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme platform technology.

  8. ENCell Signs MOU With Cell Resources Corporation To Pave Way For Market Entry To Japan 3/13/2025

    ENCell Co., Ltd., a South Korean biotech specializing in advanced biopharmaceutical contract development and manufacturing organizations (CDMO) and novel drug development, has signed an MOU for collaboration in the field of CGT with Cell Resources Corporation (CRC)— a member of Japan’s leading pharmaceutical company Alfresa Group—designed to drive the group’s expansion into the CGT market.

  9. Mallinckrodt And Endo To Combine To Create A Global, Scaled, Diversified Pharmaceuticals Leader 3/13/2025

    Mallinckrodt plc ("Mallinckrodt") and Endo, Inc. (OTCQX: NDOI) ("Endo") today announced that they have entered into a definitive agreement to combine in a stock and cash transaction to create a global, scaled, diversified pharmaceuticals leader.

  10. Batavia Biosciences Partners With VBC And MEVAC To Advance Localized Vaccine Manufacturing In Egypt 3/13/2025

    Batavia Biosciences, a leading Contract Development and Manufacturing Organization (CDMO) specializing in development and manufacturing of vaccines and viral vectors, is excited to announce a strategic collaboration with Vaccine Biotechnology City (VBC) and MEVAC, two pioneering organizations in Egypt.